GLS and metabolic dysfunction-associated steatohepatitis: Similar effects have been reported in non-alcoholic steatohepatitis where hepatic GLS expression is increased, the plasma glutamine-to-glutamate ratio is decreased and enzyme inhibition reduces the hepatocyte lipid content47.